Successfully reported this slideshow.

Top Report on Ulcerative Colitis Industry 2022

160 views

Published on

Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes ulcers in the innermost lining of the colon and rectum. The colon’s ability to absorb water is decreased, which leads to progressive loosening of the stool, bloody stool, and sometimes cramping or abdominal pain with urgency for bowel movement (CDC, 2013; NDDIC, 2013).

Published in: Health & Medicine

Top Report on Ulcerative Colitis Industry 2022

  1. 1. EpiCast Report: Ulcerative Colitis – Epidemiology Forecast to 2022 by Global data Explore all reports for “Gastrointestinal therapeutics ” market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/therapeutics/gastrointestinal -therapeutics . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  2. 2. EpiCast Report: Ulcerative Colitis – Epidemiology Forecast to 2022 The collection of ‘Gastrointestinal therapeutics’ market research reports has a new addition of “EpiCast Report: Ulcerative Colitis – Epidemiology Forecast to 2022” on RnRMarketResearch.com. Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes ulcers in the innermost lining of the colon and rectum. The colon’s ability to absorb water is decreased, which leads to progressive loosening of the stool, bloody stool, and sometimes cramping or abdominal pain with urgency for bowel movement (CDC, 2013; NDDIC, 2013). The exact cause or triggers of the disease are yet to be identified. Globally, the incidence of ulcerative colitis varied from 0.34 cases per 100,000 population in China to as high as 15.1 cases per 100,000 population in the UK in the 1990s (Lok et al., 2008; Shivananda et al., 1996). The diagnosed prevalence of the condition ranged between 6.3 cases per 100,000 population in China in 2006 and 243 cases per 100,000 populations in the UK during 2000-2002 (Lok et al., 2008; Rubin et al., 2000). Request a sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=138225 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  3. 3. EpiCast Report: Ulcerative Colitis – Epidemiology Forecast to 2022 This Report forecasts that there were 134,109 incident cases of ulcerative colitis in the 10MM in 2012, and the number of incident cases will grow 12.2% over the next decade to 150,530 incident cases. In 2012, there were 1,860,616 prevalent cases of ulcerative colitis in the 10MM. Each of the 10MM, except Germany, will see an increase in prevalent cases over the 10-year forecast period. This forecast is supported by historical data for ulcerative colitis gathered from peer-reviewed journals and country-specific studies, in addition to reports taken from national health authorities and international organizations with interests in gastroenterology or inflammatory bowel disease (IBD). Another major strength of this analysis is that to take into account historical trends of ulcerative colitis and provide a robust forecast, epidemiologists conducted linear regression analysis whenever sufficient historical data were available and the literature supported the resulting trend. Complete report available @ http://www.rnrmarketresearch.com/epicast-report-ulcerative-colitisepidemiology-forecast-to-2022-market-report.html . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  4. 4. EpiCast Report: Ulcerative Colitis – Epidemiology Forecast to 2022 For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

×